Anastrozole works by blocking the enzyme aromatase, which converts other hormones into estrogen in postmenopausal women. Because the drug is processed through specific liver pathways and its entire purpose is to suppress estrogen, two categories of supplements pose a genuine concern: those that interfere with how the drug is broken down in your body, and those that raise estrogen levels or mimic estrogen’s effects. The most clearly problematic supplement is St. John’s wort, but the list extends to several popular herbal products and concentrated botanical extracts that many people assume are harmless because they are “natural.”
Why Liver Enzymes Matter for Anastrozole
Anastrozole is metabolized primarily through the CYP3A4 enzyme system in the liver. It also interacts with CYP1A2 and CYP2C9 pathways.1PubMed. Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase Any supplement that significantly speeds up or slows down these enzymes can change the amount of active anastrozole circulating in your blood. If CYP3A4 activity increases, anastrozole gets broken down faster than it should, potentially lowering the drug to ineffective levels. If CYP3A4 is inhibited, the drug can accumulate and intensify side effects. This is the same basic mechanism behind many prescription drug interactions, but supplements are rarely tested with the same rigor, so the risk often goes unrecognized.
St. John’s Wort Is the Biggest Offender
St. John’s wort (Hypericum perforatum) is widely used for mild depression and mood support, which makes it especially tempting for women dealing with the emotional toll of breast cancer treatment. Unfortunately, St. John’s wort is one of the most potent inducers of CYP3A4 and P-glycoprotein known among herbal supplements.2PubMed Central. CAM Interactions in Breast and Other Gynecological Cancers By ramping up CYP3A4 activity, it can cause your body to clear anastrozole much faster than normal, reducing the drug’s ability to suppress estrogen. This isn’t a theoretical concern confined to lab studies; the interaction is well enough established that oncologists routinely warn against combining St. John’s wort with aromatase inhibitors. If you’re looking for mood support, talk to your oncology team about alternatives. Prescription antidepressants like certain SSRIs can be used safely alongside anastrozole, though some (like those heavily processed through CYP2D6) carry their own interaction considerations with other breast cancer drugs.
Other Herbal Supplements That Affect CYP3A4
St. John’s wort gets most of the attention, but a review of complementary and alternative medicine interactions in breast cancer identified several other herbs with potential pharmacokinetic interactions involving the CYP3A4 pathway relevant to anastrozole. These include echinacea, ginseng, green tea extract, valerian, black cohosh, ginkgo biloba, milk thistle, mistletoe, and turmeric (curcumin).2PubMed Central. CAM Interactions in Breast and Other Gynecological Cancers Some of these act as inducers, some as inhibitors, and a few do both depending on the enzyme and the dose. Echinacea, ginseng, green tea extract, and valerian, for example, can function as either inducer or inhibitor depending on which CYP enzyme is involved.
This doesn’t mean every woman who takes a ginkgo capsule while on anastrozole will experience a dangerous interaction. The clinical significance varies with dosage, duration, and individual metabolism. But the sheer number of commonly used herbal products on this list is worth paying attention to, especially because many people take several of these at once. The risk compounds when you stack multiple herbs that all push the same enzyme pathway in the same direction.
Phytoestrogens and Estrogen-Like Supplements
Since anastrozole’s entire job is to starve estrogen-receptor-positive breast cancer cells of the estrogen they need to grow, anything that adds estrogen or mimics its effects in the body could theoretically work against the drug. This makes supplements containing phytoestrogens a source of understandable worry. Red clover, dong quai, wild yam, and concentrated soy isoflavone supplements all fall into this category. The concern is that plant-derived compounds with weak estrogen-like activity might partially counteract anastrozole’s suppression of estrogen.
The picture is more nuanced than “all phytoestrogens are dangerous,” though. Soy products, which are probably the most widely consumed source of phytoestrogens, have been studied fairly extensively in this context. A review of the evidence concluded that soy does not appear to interfere with anastrozole therapy.3PubMed. Soy products in the management of breast cancer Dietary soy in moderate amounts, like tofu or edamame a few times a week, is generally considered acceptable by most oncologists. The distinction that matters is between whole food sources of soy and high-dose concentrated isoflavone supplements, which can deliver phytoestrogens at levels far beyond what you’d get from food. If a supplement label advertises concentrated isoflavones, that’s worth flagging with your care team.
Other estrogen-like botanicals are less well studied. Some natural compounds found in sesame seeds and certain plant extracts have been noted as potentially diminishing the anti-estrogenic effects of aromatase inhibitors, leading to recommendations that patients on these drugs exercise caution around dietary supplements and plants containing estrogen-like compounds.4PubMed Central. Nutritional Impact on Breast Cancer in Menopausal and Post-Menopausal Patients Treated with Aromatase Inhibitors The safest approach is to avoid concentrated hormonal botanicals. DHEA supplements, which the body can convert into both testosterone and estrogen, are another product to steer clear of entirely while on anastrozole.
The Milk Thistle Question
Milk thistle (silymarin) deserves its own discussion because it’s one of the most popular “liver support” supplements, and women on anastrozole sometimes reach for it hoping to protect their liver from the drug’s metabolic load. The evidence here is genuinely mixed. In lab studies using human liver cells, a standardized milk thistle extract at high concentrations did inhibit several CYP enzymes including CYP3A4. However, at concentrations close to what actually circulates in the blood after a normal oral dose, no meaningful inhibition was observed for CYP3A4.5PubMed. Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities A separate human study also found that exposure to milk thistle extract produced no significant influence on CYP1A2, CYP2C9, CYP2D6, or CYP3A4/5 activities.6PubMed Central. The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity
So in practice, milk thistle at standard doses probably doesn’t meaningfully alter anastrozole metabolism. But “probably doesn’t” is not the same as “definitely safe,” and the broader CAM interaction review still flags milk thistle as a potential CYP3A4 concern for patients on anastrozole.2PubMed Central. CAM Interactions in Breast and Other Gynecological Cancers If you’re currently taking milk thistle, this is a reasonable topic to bring up with your oncologist rather than something to panic about. The interaction risk appears low but hasn’t been definitively ruled out in clinical trials of cancer patients.
Supplements That Are Generally Safe and Even Encouraged
Not everything on the supplement shelf is a concern. Some products are actively recommended for women on aromatase inhibitors because they help manage known side effects of the drug.
Calcium and vitamin D are the most important. Anastrozole accelerates bone density loss because estrogen normally helps maintain bone health. Without it, women on aromatase inhibitors face higher fracture risk. Calcium and vitamin D supplementation is standard practice, though a review of 16 trials found that the doses typically tested (500 to 1,500 mg of calcium and 200 to 1,000 IU of vitamin D) were not enough on their own to fully prevent bone mineral density loss in women undergoing breast cancer therapy.7PubMed Central. Calcium and vitamin D supplementation and loss of bone mineral density in women undergoing breast cancer therapy That doesn’t mean you shouldn’t take them; it means they’re a necessary piece of the bone-protection puzzle, just not the entire puzzle. Many oncologists combine calcium and vitamin D with prescription bone-protective drugs like bisphosphonates or denosumab for women at higher fracture risk.
Melatonin is another supplement with a reassuring profile for anastrozole users. Research suggests melatonin has antiestrogenic properties and may actually complement aromatase inhibitors rather than oppose them. It has been described as capable of reducing body fat mass and inhibiting aromatase expression, and researchers have proposed it could safely be associated with the antiestrogenic drugs currently used for breast cancer.8PubMed Central. Melatonin: A Molecule for Reducing Breast Cancer Risk Given how common sleep disruption is for women dealing with treatment-related hot flashes, melatonin’s compatibility with anastrozole is welcome news.
Managing Joint Pain Without Undermining Your Treatment
Joint pain and stiffness are among the most common and most bothersome side effects of aromatase inhibitors. Roughly half of women on these drugs report musculoskeletal symptoms, and it’s one of the leading reasons women consider stopping treatment early. Naturally, many turn to supplements for relief.
Omega-3 fatty acids (fish oil) have been studied specifically for aromatase inhibitor-related joint pain. In a randomized trial, omega-3 supplements showed a meaningful benefit for obese patients, with significantly lower pain scores at 24 weeks compared to placebo. However, in non-obese patients, there was no significant difference between the fish oil and placebo groups.9PubMed Central. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927) Fish oil doesn’t appear to interfere with anastrozole’s metabolism, so it’s generally considered safe to try, with the caveat that the pain-relief benefit may vary by body composition.
Glucosamine and chondroitin, a combination commonly used for osteoarthritis, has also been tested for aromatase inhibitor-related joint pain. In a phase II clinical trial, about 46% of participants reported a meaningful improvement in joint pain after six months. The supplements were well tolerated with minimal side effects, and importantly, glucosamine and chondroitin did not change estradiol levels in postmenopausal breast cancer survivors on aromatase inhibitors.10PubMed Central. Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer That last point is critical: these supplements didn’t raise estrogen. From a safety standpoint, glucosamine and chondroitin appear to be a reasonable option to discuss with your care team if joint pain is affecting your quality of life.
Turmeric (curcumin) is another popular choice for joint inflammation, but it sits in a more complicated category. While its anti-inflammatory properties are well documented, turmeric has been flagged for potential CYP3A4 and P-glycoprotein interactions with anastrozole.2PubMed Central. CAM Interactions in Breast and Other Gynecological Cancers The clinical significance at typical dietary doses is unclear, but concentrated curcumin supplements deliver much higher doses than you’d get from cooking with turmeric powder. If you’re using turmeric as a spice in food, that’s likely fine. If you’re taking high-dose curcumin capsules specifically for joint pain, that warrants a conversation with your doctor.
Black Cohosh and Red Clover for Hot Flashes
Hot flashes are arguably the most universal side effect of estrogen suppression, and two of the most popular herbal remedies for menopausal symptoms are black cohosh and red clover. These raise questions for women on anastrozole because both have at least some association with hormonal activity.
A 12-month randomized controlled trial comparing black cohosh and red clover against placebo found no significant differences in any safety parameters, including breast safety, endometrial safety, liver enzymes, or blood counts. There was no evidence of liver toxicity from black cohosh, and red clover did not interfere with blood coagulation.11PubMed Central. Safety and Efficacy of Black Cohosh and Red Clover for the Management of Vasomotor Symptoms: A Randomized Controlled Trial That’s reassuring from a general safety standpoint. However, this study was conducted in healthy menopausal women, not specifically in breast cancer patients on aromatase inhibitors. And black cohosh does appear on the list of herbs with potential CYP3A4 interactions relevant to cancer drugs.2PubMed Central. CAM Interactions in Breast and Other Gynecological Cancers The clinical implications of this interaction for anastrozole specifically haven’t been nailed down in large trials, so the evidence doesn’t clearly forbid black cohosh, but it doesn’t give it an unambiguous green light either.
How Common Are Risky Supplement Combinations?
The scale of the problem is larger than most people realize. In a study of 475 breast cancer survivors, 83% reported using dietary supplements, and among women taking tamoxifen or aromatase inhibitors specifically, 38% were taking at least one dietary supplement with a potential risk of interaction with their prescribed endocrine therapy.12PubMed Central. Dietary Supplement Use and Interactions with Tamoxifen and Aromatase Inhibitors in Breast Cancer Survivors Enrolled in Lifestyle Interventions The researchers identified 108 different types of dietary supplements in use and flagged 36 potential adverse interactions. That means more than one in three women on these drugs was unknowingly taking something that could undermine their treatment or increase side effects.
A separate study of supplement patterns among women diagnosed with breast cancer confirmed the breadth of the issue. About 90% reported using vitamins or minerals, and about two-thirds used non-vitamin, non-mineral products. The most popular supplements included vitamin D, calcium, multivitamins, vitamin C, probiotics, turmeric, fish oil, melatonin, and cannabis products.13PubMed Central. Dietary Supplement Use in Women Diagnosed with Breast Cancer Several of those, including turmeric and cannabis, have potential pharmacokinetic interactions with aromatase inhibitors that many women may not be aware of. Nearly half of vitamin and mineral users reported taking three or more products at the same time, compounding the chance of at least one problematic interaction.
The Gut Microbiome Angle
An emerging area of research looks at how your gut bacteria interact with breast cancer treatments, including aromatase inhibitors. Gut microbes produce enzymes that can reactivate estrogen that your body has already tagged for elimination. Certain bacteria produce beta-glucuronidase enzymes that strip the inactivating tag off estrogen metabolites, allowing them to be reabsorbed back into circulation rather than excreted. Research indicates that only about 7% of conjugated estrogen metabolites are actually excreted; most are recycled through this bacterial process.14PubMed Central. Gut microbiota interact with breast cancer therapeutics to modulate efficacy
This matters for the supplement question because probiotics, prebiotics, and other gut-modifying supplements could theoretically shift the composition of your gut microbiome in ways that affect estrogen recycling. If a probiotic promotes the growth of bacterial species that produce more beta-glucuronidase, it could increase circulating estrogen, which is exactly what anastrozole is trying to reduce. The research in this area is still early, and nobody has demonstrated that a specific off-the-shelf probiotic product meaningfully interferes with anastrozole in a clinical setting. But the biological mechanism is plausible enough that researchers are paying attention. For now, standard probiotics taken for digestive comfort are unlikely to pose a significant risk, but high-dose or targeted microbiome products marketed with bold health claims deserve more skepticism.
A Practical Approach to Supplement Decisions
The safest move is to bring every supplement bottle to your oncology appointment and go through them one by one. That sounds tedious, but given that more than a third of women on aromatase inhibitors are unknowingly taking something potentially problematic, it’s clearly necessary. Many oncology practices now routinely ask about supplement use, but the conversation doesn’t always happen in enough detail, especially when patients are taking several products.
As a rough guide, supplements fall into a few practical categories for anastrozole users:
- Avoid entirely: St. John’s wort, DHEA, concentrated isoflavone supplements, and any product marketed as raising or balancing estrogen or testosterone.
- Use with caution and disclose: Turmeric/curcumin at high doses, echinacea, ginseng, ginkgo biloba, valerian, green tea extract in supplement form, black cohosh, and cannabis products. These have flagged interactions but uncertain clinical significance at standard doses.
- Generally safe and often recommended: Calcium, vitamin D, omega-3 fish oil, glucosamine/chondroitin, and melatonin. These either lack evidence of interference or have been specifically tested in aromatase inhibitor users without showing problems.
One thing to keep in mind is that “green tea extract supplement” and “drinking green tea” are not the same thing. Concentrated botanical extracts deliver compounds at doses many times higher than what you’d consume in food. The dose matters enormously for interactions. A cup of green tea or a meal cooked with turmeric is a very different proposition from a capsule containing a concentrated extract of either. When interaction databases flag a botanical, they’re usually talking about supplement-level doses, not the amounts found in a normal diet.
Why Your Pharmacist May Know More Than Your Oncologist About This
Oncologists are experts in cancer treatment, but clinical pharmacists are specifically trained in drug-drug and drug-supplement interactions. Many cancer centers now include a pharmacist on the care team, and if yours does, that person is often the best resource for evaluating whether a specific supplement at a specific dose is likely to cause trouble. Pharmacists have access to interaction databases that can flag potential CYP enzyme conflicts in real time. If your cancer center doesn’t have an embedded pharmacist, your community pharmacist can still run an interaction check. The key is not to assume that because something is sold over the counter, it’s been vetted for safety alongside prescription cancer medications. Supplement manufacturers are not required to test for interactions with chemotherapy or endocrine therapy, and most never do.